WiQo PRX-PLUS Treatment in Singapore
Doctor-led professional topical treatment for selected concerns involving uneven tone, visible pores, texture and early skin laxity. PRX-PLUS is applied to the skin without needles and is designed to work without the visible frosting and peeling associated with conventional medium-depth chemical peels.
PRX-PLUS is a newer WiQo formulation. It should not be described as identical to the older PRX-T33 formulation or marketed through celebrity claims.
This distinction is the single most important thing to understand before booking. A great deal of the material circulating about “PRX” online — including published studies and before-and-after claims — concerns the earlier formulation. Evidence for one product is not evidence for another simply because the names are similar.
PRX-PLUS at a glance
| What it is | A patented professional topical formulation applied in clinic by a trained practitioner, without needles |
|---|---|
| Current formulation | Manufacturer information describes a basis of homocysteic acid, ammonium trichloroacetate and other actives |
| Not the same as | PRX-T33, the earlier formulation based on TCA, hydrogen peroxide and kojic acid |
| Positioned for | Uneven-looking tone, texture and visible pores, and the appearance of skin density and early laxity |
| Design intent | To act without producing the visible frosting and peeling of a conventional medium-depth peel |
| Typical downtime | Often limited, but transient redness, stinging, tightness or dryness can still occur |
| Sessions | Protocol-dependent, commonly a short initial course with review. No universal number applies |
| Evidence status | PRX-PLUS-specific peer-reviewed evidence is currently limited compared with the wider chemical-peel literature |
| Where | Aquila Medical Center, 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914 |
What is PRX-PLUS?
WiQo describes PRX-PLUS as a patented professional topical formulation intended for trained practitioners. Current manufacturer information describes a formulation based on homocysteic acid, ammonium trichloroacetate and other active ingredients.
This is important because older PRX-T33 literature and marketing frequently refer to a different TCA, hydrogen-peroxide and kojic-acid formulation. Evidence from the older product should not automatically be presented as if it were evidence for the current PRX-PLUS formula.
The concept behind this family of products is worth understanding. Conventional trichloroacetic acid peels work partly by damaging the epidermis, which is what produces frosting and subsequent peeling. These formulations aim instead to reach the dermis and provoke a remodelling response while limiting epidermal injury — which is the basis for the “no visible peeling” positioning. Whether that translates into the same magnitude of benefit as a conventional peel is a separate question, and one the current evidence does not settle.
Terminology: PRX-PLUS is often grouped with “chemical peels,” but its clinical positioning is different from a conventional peel designed to create visible epidermal exfoliation. Aquila describes it as a professional topical skin treatment rather than promising a fixed peel depth.
The practical appeal is real, particularly in Singapore. A treatment that avoids visible peeling suits working patients who cannot take social downtime, and it avoids the sun-exposure vulnerability that follows a conventional peel in a year-round high-ultraviolet climate. Those are legitimate advantages even where the evidence base is thinner.
What may improve?
Uneven-looking tone
The manufacturer positions PRX-PLUS for a brighter, more even appearance in selected pigmented or photodamaged skin. Underlying melasma, PIH or suspicious lesions still require diagnosis.
Texture and visible pores
Selected patients may notice smoother texture or reduced pore visibility. Pores cannot be permanently closed, and acne scars require separate assessment.
Early laxity / skin density
PRX-PLUS is positioned for improvement in the appearance of tone and skin density. It does not remove substantial excess skin or replace surgical lifting.
Where downtime is the constraint
Its clearest practical advantage is for patients who cannot accept visible peeling but want more than a superficial facial.
Body areas
Some protocols are used on the neck, chest and hands, where skin is thinner and heals differently. Expectations and protocols differ from facial treatment.
What it will not do
It is not a treatment for established atrophic scars, deep wrinkles, significant laxity, discrete pigmented lesions or active acne.
PRX-PLUS versus a traditional chemical peel
| Feature | PRX-PLUS | Conventional chemical peel |
|---|---|---|
| Application | Topical professional application without needles. | Topical acid solution selected by agent, concentration and desired depth. |
| Visible exfoliation | Designed to avoid obvious frosting or visible peeling. | May intentionally produce epidermal exfoliation or deeper controlled injury. |
| Downtime | Often limited, but redness, sensitivity or dryness can still occur. | Varies widely from minimal to substantial according to peel depth. |
| Sun-exposure vulnerability | Lower, since the epidermal barrier is less disrupted. | Higher after medium or deep peels, which matters in a high-ultraviolet climate. |
| Predictability of depth | Not defined by a conventional peel-depth endpoint. | Depth can be titrated by agent and concentration with recognised clinical endpoints. |
| Evidence | Current PRX-PLUS-specific peer-reviewed evidence is more limited than the broader literature on chemical peeling. | TCA, glycolic, salicylic and other peels have broader published clinical literature for selected indications. |
Neither is universally better. A conventional peel offers a longer evidence record and titratable depth at the cost of downtime and post-peel photosensitivity; PRX-PLUS offers convenience and a gentler barrier impact with a thinner evidence base behind the specific current formulation.
PRX-PLUS is not a replacement for every pigmentation treatment
Brown facial pigmentation can represent freckles, solar lentigines, melasma, post-inflammatory hyperpigmentation, seborrhoeic keratoses or other lesions. These conditions behave differently.
A topical brightening treatment may be reasonable for selected diffuse tone concerns, but a discrete lentigo may respond better to pigment-targeted laser, while melasma often requires a combination of photoprotection, topical therapy and careful device selection.
Melasma warrants specific caution. It is an inflammation-sensitive condition that can be provoked by treatments intended to improve it, and any procedure carrying a risk of irritation deserves a conservative approach and a low threshold for stopping. A gentler treatment is not automatically a safe treatment in melasma.
What happens during treatment?
Assessment
The doctor reviews skin type, active dermatitis or acne, pigmentation diagnosis, recent procedures, medications and sensitivity before deciding whether PRX-PLUS is appropriate.
Application
The professional solution is applied topically using the protocol appropriate to the area and skin condition. No injections are required.
Aftercare
Sun protection and gentle skincare remain important. Product-specific home care may be recommended according to the treatment plan.
| Period | What is typical | What matters most |
|---|---|---|
| During application | Stinging or warmth as the solution is worked into the skin. Intensity varies with skin condition. | Tell the practitioner if discomfort is more than moderate. |
| First 24 hours | Redness and a tight sensation. Skin often looks brighter immediately, partly from hydration. | Gentle cleansing, generous moisturiser, strict sun protection. |
| Days 2–5 | Tightness settles. Mild dryness or fine flaking occurs in some patients despite the no-peel design. | Do not exfoliate or use actives. Let any flaking resolve on its own. |
| Weeks 1–4 | Any textural and tone change becomes more apparent. Further sessions in a course are usually scheduled here. | Standardised photography rather than impression. |
| Beyond the course | Benefit is maintained by home care and photoprotection rather than by the treatment alone. | Honest reassessment before committing to maintenance. |
Home care is part of the protocol rather than an upsell in this case: the manufacturer's approach pairs in-clinic application with specific home products, and results reported for the treatment generally assume that pairing. It is fair to ask what the home-care component costs before starting, so the total is clear.
Downtime and possible side effects
The absence of visible peeling does not mean the skin cannot react. Temporary redness, stinging, dryness, sensitivity, tightness or irritation can occur. Patients with an impaired skin barrier, active eczema, infection or inflammatory flare may need to postpone treatment.
Post-inflammatory hyperpigmentation is possible after any procedure that causes inflammation, particularly in darker skin types. Aggressive combination treatment on the same day should therefore be individualized rather than assumed to be safe.
Other reasons to defer include pregnancy and breastfeeding, recent isotretinoin, active cold sores, recent resurfacing or laser treatment in the same area, and known sensitivity to any component. Recent significant sun exposure is also worth mentioning, since more reactive skin responds less predictably.
Seek review for marked swelling, blistering, persistent severe burning, crusting, discharge or a progressive rash after treatment.
What does the evidence tell us?
Trichloroacetic-acid-based peeling has an established literature for photoageing and selected pigmentary concerns. However, studies differ greatly in formulation, concentration and depth, and many PRX publications concern older peroxide/TCA formulations rather than current PRX-PLUS.
For that reason, Aquila does not transfer every result reported for PRX-T33 or conventional TCA peels directly onto PRX-PLUS. Expected benefit is discussed conservatively and reassessed after treatment.
Being clear about what “limited evidence” means here: it indicates that high-quality trials of this specific current formulation are few, not that the treatment has been shown not to work. Those are different statements, and honest practice sits between dismissing the treatment and overselling it. Patients who value a long published record may reasonably prefer better-studied alternatives; patients who value minimal downtime may reasonably accept a thinner evidence base for a low-risk topical treatment.
A reasonable approach is to trial a short course, assess it honestly against baseline photographs, and stop if the change does not justify the cost. That is a better basis for decision-making than either marketing enthusiasm or blanket scepticism.
Frequently asked questions
Is PRX-PLUS the same as PRX-T33?
No. PRX-PLUS is a newer WiQo formulation. Current manufacturer information describes different key ingredients from the older PRX-T33 TCA/peroxide/kojic-acid formulation.
Does PRX-PLUS cause peeling?
It is designed to avoid visible exfoliation, but temporary dryness, sensitivity or mild flaking can still occur in individual patients.
Is there zero downtime?
Aquila does not promise zero downtime. Many patients can resume routine activity quickly, but transient redness or sensitivity is possible.
How many sessions do I need?
There is no universal number. Frequency depends on the skin concern, response and the professional protocol used.
Can it treat acne scars?
It may improve general texture, but established atrophic scars usually require scar-specific treatment such as fractional laser, RF microneedling, subcision or focal techniques.
Does it hurt?
Most patients describe stinging or warmth during application rather than significant pain. Intensity varies with skin condition and how compromised the barrier is beforehand.
Can I have it before an event?
It is among the more event-friendly treatments because visible peeling is not intended, but allow several days for any redness to settle rather than treating the day before.
Is it safe for darker skin types?
It can be used across skin types, but any treatment causing inflammation carries post-inflammatory hyperpigmentation risk in Fitzpatrick III to V skin. Conservative protocols and strict photoprotection matter.
Can it be used for melasma?
Only with caution. Melasma is inflammation-sensitive and can be provoked by treatments intended to improve it, so a gentler treatment is not automatically a safe treatment here.
Can I use it on my neck, chest or hands?
Some protocols address these areas, but the skin is thinner and heals differently, so expectations and protocols differ from facial treatment.
Do I need to buy the home-care products?
The manufacturer's approach pairs in-clinic application with specific home care, and reported results generally assume that pairing. Ask what the home-care component costs so the total is clear before starting.
When will I see results?
Skin often looks brighter immediately, partly from hydration. More meaningful textural and tone change is assessed over the following weeks and across a course rather than after one application.
How long do results last?
Benefit is maintained by home care and photoprotection rather than by the treatment alone. Without those, change fades as photodamage continues.
Can it be combined with other treatments?
Sometimes, but combining procedures on the same day increases irritation and pigmentary risk. Sequencing should be planned rather than stacked for convenience.
Can I have it while pregnant or breastfeeding?
Elective aesthetic treatment is conventionally postponed during pregnancy, and treatment should be discussed rather than assumed during breastfeeding.
Is the evidence strong?
Evidence for this specific current formulation is limited, which means few high-quality trials rather than evidence it does not work. Patients who value a long published record may prefer better-studied alternatives.
Should I have it if I have active acne or eczema?
Generally not while the skin is actively inflamed or the barrier is impaired. Settling the underlying condition first produces a better and safer result.
What should I avoid before treatment?
Strong actives such as retinoids and exfoliating acids for several days beforehand, deliberate sun exposure, and any recent resurfacing in the same area. Declare recent isotretinoin use.
Is PRX-PLUS claimable under MediSave or insurance in Singapore?
Aesthetic treatment for cosmetic indications is generally not claimable under MediSave or most private insurance policies. Check directly with your insurer.
Where is Aquila Medical Center?
Aquila Medical Center is at 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914, in the Singapore CBD, a short walk from Tanjong Pagar, Shenton Way and Telok Ayer MRT stations.
Selected references and product information
- WiQo professional product information: PRX-PLUS.
- WiQo professional information describing current PRX-PLUS formulation.
- Trichloroacetic acid peeling for photoageing: systematic review.
- TCA-peroxide formulation for chrono- and photodamaged skin.
- Post-inflammatory hyperpigmentation: a systematic review of treatment outcomes.
- American Academy of Dermatology. Melasma: diagnosis and treatment.
This page is educational and does not replace an individual skin assessment. Suitability, protocol and expected benefit depend on your skin type and diagnosis. Results vary between individuals and no outcome can be guaranteed. Content reviewed by the medical team at Aquila Medical Center, Singapore. Last reviewed: 26 August 2026.
Doctor-led PRX-PLUS assessment in Singapore
The useful question is whether a professional topical treatment is appropriate for the diagnosed skin concern — not whether a product has been associated with a celebrity or described as a “no-downtime miracle.” Aquila matches the treatment to skin type, pigmentation diagnosis and realistic goals.
Aquila Medical Center is located at 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914, a short walk from Tanjong Pagar, Shenton Way and Telok Ayer MRT stations. Where a better-studied treatment would suit your diagnosis, we will say so.